Currently, Stephen Brannan occupies the position of Chief Medical Officer at Karuna Therapeutics, Inc.

He is also Member of International Society for CNS Drug Development, Member of American College of Neuropsychopharmacology, Member of International Society For Cns Clinical Trials & Methodology, Member of Alan Aragon's Research Review and Member of Cns Summit.

In the past he was Vice President-Clinical Research & Medical Affairs at FORUM Pharmaceuticals, Inc. and Head-Neuroscience at Takeda Pharmaceutical Co., Ltd.

Dr. Brannan received an undergraduate degree from Harvard College and a doctorate from The University of Texas Southwestern Medical Center.